|
|
|
|||||||||||||
|
|
||||||||||||||
|
|
||||||||||||||
|
|
||||||||||||||
|
|
||||||||||||||
|
|
||||||||||||||
|
DAVID MEE-LEE, M.D. David Mee-Lee, M.D. is a board-certified
psychiatrist with a Certificate of Added Qualification in Addiction Psychiatry,
and is certified by examination of the American Society of Addiction Medicine
(ASAM). He is an Assistant Clinical Professor, University of California at
Davis, School of Medicine, Department of Psychiatry. Based in Davis, California, Dr. Mee-Lee is
involved in training and consultation full-time and also consults to national
managed behavioral healthcare companies. He has focused for over twenty years,
on developing and promoting innovative behavioral health treatment that values
clinical integrity, high quality, and cost-consciousness. In addition, he has
more than twenty years experience with dual diagnosis (co-occurring addiction
and mental illness) treatment and program development. Dr. Mee-Lee has authored a number of book
chapters and papers in a variety of professional publications. He is Chair of
the Criteria Committee of the American Society of Addiction Medicine (ASAM) and
is Chair of the Coalition for National Clinical Criteria. He
was one of the authors of the Cleveland Criteria; and also the first edition
and seconds of the ASAM Criteria; and is the Chief Editor of the Revised Second
Edition of the ASAM Patient Placement Criteria for the Treatment of
Substance-Related Disorders, ASAM PPC-2R, published in April, 2001. David Mee-Lee, M.D.
© 2005 Evince Clinical Assessments |